113 POSTER Phase II trial to assess the activity of MVA5T4 (Trovax®) alone versus MVA5T4 plus granulocyte macrophage colony-stimulating factor (GM-CSF) in patients (pts) with progressive hormone refractory prostate cancer (HRPC)

2006 ◽  
Vol 4 (12) ◽  
pp. 38
Author(s):  
R. Amato ◽  
M. Karediy ◽  
A. Cao ◽  
M. Khan ◽  
S. Naylor ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document